Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.70p
   
  • Change Today:
      0.000p
  • 52 Week High: 2.85
  • 52 Week Low: 0.42
  • Currency: UK Pounds
  • Shares Issued: 374.35m
  • Volume: 378,644
  • Market Cap: £2.62m
  • RiskGrade: 435

Latest ShareCast News

Ambrose exercises ValiRx oncology option worth up to £16m

By Josh White

Date: Friday 20 Jun 2025

(Sharecast News) - ValiRx confirmed on Friday that Ambrose Healthcare has exercised its option to license the VAL401 oncology asset, in a deal worth up to £16m plus royalties.

ValiRx terminates exclusive negotiations with TheoremRx

By Josh White

Date: Thursday 03 Apr 2025

(Sharecast News) - ValiRx announced the immediate termination of its letter of intent with TheoremRx on Thursday, ending exclusive negotiations originally set to run until 31 May.

ValiRx's Inaphaea inks deal with UK-based Screenin3D

By Josh White

Date: Monday 03 Feb 2025

(Sharecast News) - ValiRx announced on Monday that its wholly-owned subsidiary Inaphaea BioLabs has signed an evaluation and commercial use agreement with UK-based Screenin3D.

ValiRx enters evaluation and option deal with Ca... 29-Jan-2025 ShareCast
ValiRx further extends letter of intent with The... 31-Dec-2024 ShareCast
ValiRx shares tank on £1.6m fundraising plan to ... 09-Dec-2024 ShareCast
ValiRx subsidiary makes first sale 18-Nov-2024 ShareCast
ValiRx losses narrow in first half 27-Sep-2024 ShareCast
ValiRx pulls out of University of Barcelona coll... 26-Sep-2024 ShareCast
ValiRx subsidiary inks agreement with research f... 18-Sep-2024 ShareCast
ValiRx inks deal with Dundee Drug Discovery Unit 12-Feb-2024 ShareCast
ValiRx enters option deal with Ambrose Healthcare 05-Dec-2023 ShareCast
ValiRx enters partnership with StingRay Bio 10-Nov-2023 ShareCast
ValiRx shares jump as H1 losses shrink 24-Aug-2023 ShareCast
ValiRx subsidiary Inaphaea signs deal with Agili... 14-Aug-2023 ShareCast
ValiRx terminates collaboration with Hokkaido Un... 16-Jun-2023 ShareCast
ValiRx acquires assets of in-liquidation Imagen ... 14-Jun-2023 ShareCast
ValiRx incorporates new wholly-owned lab subsidi... 01-Mar-2023 ShareCast
ValiRx forms new majority-owned breast cancer su... 24-Oct-2022 ShareCast
ValiRx expecting to grant extension of exclusivi... 17-Jun-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.70p
Change Today 0.000p
% Change 0.00 %
52 Week High 2.85
52 Week Low 0.42
Volume 378,644
Shares Issued 374.35m
Market Cap £2.62m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.86% above the market average30.86% above the market average30.86% above the market average30.86% above the market average30.86% above the market average
47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average
Price Trend
89.42% below the market average89.42% below the market average89.42% below the market average89.42% below the market average89.42% below the market average
82.61% below the sector average82.61% below the sector average82.61% below the sector average82.61% below the sector average82.61% below the sector average
Income Not Available
Growth
25.37% above the market average25.37% above the market average25.37% above the market average25.37% above the market average25.37% above the market average
37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average

Valirx Dividends

No dividends found

Trades for 17-Jul-2025

Time Volume / Share Price
10:02 250,000 @ 0.66p
09:27 79,905 @ 0.72p
09:13 6 @ 0.66p
08:52 5,000 @ 0.71p
08:07 43,733 @ 0.71p

Valirx Key Personnel

CFO Gerald Desler

Top of Page